Abstract
Non-Hodgkin¡¯s lymphomas that develop and remained limited to the CNS (and the eye) are classified as primary CNS lymphomas (PCNSL). They arise from the brain, the spinal cord, leptomeninges, or eyes. Originally described as perithelial sarcoma microglioma, or reticulum sarcoma, most PCNSL proved to be of B cell origin following the introduction of immunohistochemical studies of surface markers (Burstein et al. 1963; Rubinsten 1972; Taylor et al. 1978).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abrey LE, DeAngelis LM, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16: 3, 859–C863
Auperin I, Mikol TJ, Oksenhendler E, Thiebaut JB, Brunet M, Dupont B, Morinet F (1994) Primary central nervous system malignant non-Hodgkin¡¯s lymphomas from HIV-infected and non-infected patients: expression of cellular surface proteins and Epstein-Barr viral markers. Neuropathol Appl Neurobiol 20: 3, 243–C252
Baumgartner JE, Rachlin JR, Beckstead JH, Meeker TC, Levy RM, Wara WM, Rosenblum ML. (1990) Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 73: 2, 206–C211
Brada M, Dearnaley D, Horwich A, Bloom HJ (1990) Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone. Int J Rad Oncol Biol Phys 18: 4, 787–C792
Burstein SD, Kernohan JW, Uihlein A (1963) Neoplasms of the reticuloendothelial system of the brain. Cancer 289:16
Camilleri-Broet S, Martin A, Moreau A, Angonin R, Henin D, Gontier MF, Rousselet MC, Caulet Maugendre S, Cuilliere P, Lefrancq T, Mokhtari K, Morcos M, Broet P, Kujas M, Hauw JJ, Desablens B, Raphael M (1998) Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Am J Clin Pathol 110: 5, 607–C612
Chamberlain MC, Levin VA (1992) Primary central nervous system lymphoma: a role for adjuvant chemotherapy. J Neurooncol 14: 3, 271–C275
Chang KL, Flaris N, Hickey WF, Johnson RM, Meyer JS, Weiss LM (1993) Brain lymphomas of immunocompetent and immunocompromised patients: study of the association with Epstein-Barr virus. Mod Pathol 6: 4, 427–C432
Ciricillo SF, Rosenblum ML (1990) Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg 73: 5, 720–C724
Craig FE, Gulley ML, Banks PM (1993) Posttransplantation lymphoproliferative disorders. Am J Clin Pathol 99: 3, 265–C276
DeAngelis LM (1995) Current management of primary central nervous system lymphoma. Oncology 9: 1, 63–C71
DeAngelis LM, Wong E, Rosenblum M, Furnaux H (1992) Epstein-Barr virus in acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma. Cancer 70: 6, 1607–C1611
DeAngelis LM, Yahalom J, Heinemann MH, Cirrincione C, Thaler HT, Krol G (1990) Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology 40: 1, 80–C86
DeAngelis LM, Yahalom J, Rosenblum M, Posner JB (1987) Primary CNS lymphoma: managing patients with spontaneous and AIDS related-disease. Oncology 1: 6, 52–C62
DeAngelis LM, Yahalom J, Thaler HT, Kher U (1992) Combined modality treatment for primary CNS lymphoma. J Clin Oncol 10: 4, 635–C643
Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC (1988) Increasing incidence of primary brain lymphoma in the US. Cancer 62: 11, 2461–C2465
Edgar R, Dutcher TF (1961) Histopathology of the Bing-Neel syndrome. Neurology 11: 239–C245
Ferracini R, Bergmann M, Pileri S, Rigobello L, Azzolini U, Manetto V, Poggi S, Sabattini E, Frank G, Spagnolli F (1995) Primary T-cell lymphoma of the central nervous system. Clin Neuropathol 14: 3, 125–C129
Formenti SC, Gill PS, Lean E, Rarick M, Meyer PR, Boswell W, Petrovich Z, Chak L, Levine AM (1989) Primary central nervous system lymphoma in AIDS. Results of radiation therapy. Cancer 63: 6, 1101–C1107
Forsyth PA, Yahalom J, DeAngelis LM (1994) Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 44: 8, 1473–C1479
Freilich RJ, Delattre JY, Monjour A, DeAngelis LM (1996) Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 46: 2, 435–C439
Gabbai AA, Hochberg FH, Linggood RM, Bashir R, Hotleman K (1989) High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases. J Neurosurg 70: 2, 190–C194
Gametchu B (1987) Glucocorticoid receptor-like antigen in lymphoma cell membranes: correlation to cell lysis. Science 236: 4800, 456–C461
Geddes JF, Bhattacharjee MB, Savage K, Scaravilli F, McLaughlin JE (1992) Primary cerebral lymphoma: a study of 47 cases probed for Epstein-Barr virus genome. J Clin Pathol 45: 7, 587–C590
Gill PS, Levine AM, Meyer PR, Boswell WD, Burkes R, Parker JW, Hofman FM, Dworsky RL, Lukes RJ (1985) Primary central nervous system lymphoma in homosexual men. Clinical, immunologic and pathologic features. Am J Med 78: 5, 742–C748
Grant JW, Gallagher PJ, Jones DB (1986) Primary cerebral lymphoma. A histologic and immunohistochemical study of six cases. Arch Pathol Lab Med 110: 10, 897–C901
Greig NH, Ries LG, Yancik R, Rapoport SI (1990) Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 82: 20, 1621–C1624
Guinan ME, Hardy A (1981 through 1986) Epidemiology of AIDS in women in the United States. JAMA 257: 2039–C2042
Gunderson CH, Menry J, Malamud N (1971) Plasma globulin determinations in patients with microglioma. Report of five cases. J Neurosurg 35: 4, 406–C415
Hamilton-Dutoit SJ, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, Oksenhendler E, Marelle L, Pallesen G (1993) In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 82: 2, 619–C624
Henderson S, Rowe M, Gregory C, Croom Carter D, Wang F, Longnecker R, Kieff E, Rickinson A (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 7, 1107–C1115
Henry JM, Heffner RR Jr, Dillard SH, Earle KM, Davis RL (1974) Primary malignant lymphomas of the central nervous system. Cancer 34: 4, 1293–C1302
Hochberg FH, Miller DC (1988) Primary central nervous system lymphoma. J Neurosurg 68: 6, 835–C853
Hoover R, Fraumeni Jr JF. (1973) Risk of cancer in renaltransplant recipients. Lancet 2: 7820, 55–C57
Ironside JW (1992) Epstein-Barr virus gene expression in CNS lymphomas. Clin Neuropathol 11:210
Jellinger K, Radaskiewicz TH, Slowik F (1975) Primary malignant lymphomas of the central nervous system in man. Acta Neuropathol (Berlin) Suppl 6: 95–C102
Jellinger KA, Paulus W (1995) Primary central nervous system lymphomas: new pathological developments. J Neurooncol 24: 1, 33–C36
Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, Herndier B, Northfelt DW, Huang J, Tulpule A, Levine AM (1997) Low-dose compared with standard-dosem-BACOD chemotherapy for non-Hodgkin¡¯s lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group N Eng J Med. 336: 23, 1641–C1648
Karp JE, Broder S (1992) The pathogenesis of AIDS lymphoma: a foundation for addressing the challenges of therapy and prevention. Leuk Lymphoma 8: 3, 167–C188
Krogh-Jensen M, Johansen P, D¡¯ Amore F (1998) Primary central nervous lymphomas in immunocompetent individuals: histology, Epstein-Barr virus genome, Ki-67 proliferation index, p53 and bcl-2 gene expression. Leuk and Lymphoma 30: 1–C2, 131–C142
Lachance DH, O¡¯Neill BP, Macdonald DR, Jaeckle KA, Witzig TE, Li CY, Posner JB (1991) Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis and review of the literature. Neurology 41: 1, 95–C100
Levine AM, Sullivan-Halley J, Pike MC, Rarick MU, Loureiro C, Bernstein-Singer M, Willson E, Brynes R, Parker J, Rasheed S, et al. (1991) Human immunodeficiency virusrelated lymphom. Prognostic factors predictive of survival. Cancer 68: 11, 2466–C2472
Ling SM, Roach M 3rd, Larson DA, Wara WM (1994) Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Ten years of treatment experience at the University of California San Francisco. Cancer 73: 10, 2570–C2582
Littman P, Wang CC (1975) Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases. Cancer 35: 5, 1412–C1420
Margolis L, Fraser R, Lichter A, Char DH (1980) The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer 45: 4, 688–C692
Marsh WL Jr, Stevenson DR, Long HJ (1983) Primary leptomeningeal presentation of T-cell lymphoma. Report of a patient and review of the literature. Cancer 51: 6, 1125–C1131
Morgello S, Maiese K, Petito CK (1989) T-cell lymphoma in the CNS: clinical and pathologic features. Neurology 39: 9, 1190–C1196
Murphy JK, Young LS, Bevan IS, Lewis FA, Dockey D, Ironside JW, OBrien CJ, Wells M (1990) Demonstration of Epstein- Barr virus in primary brain lymphoma by in situ DNA hybridisation in paraffin wax embedded tissue. J Clin Pathol 43: 3, 220–C223
Murray K, Kun L, Cox J (1986) Primary malignant lymphomas of the central nervous system. J Neurosurg 65:600–C607
Nakhleh RE, Manivel JC,Hurd D,Sung JH (1989) Central nervous system lymphomas. Immunohistochemical and clinicopathologic study of 26 autopsy cases. Arch Pathol Lab Med 113: 9, 1050–C1056
Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, Kerman HD, Thomson JW, Murray KJ (1992) Non-Hodgkin¡¯s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a perspective trial by 436 S. C. Formenti and A. Bettini the Radiation Therapy Oncology Group (RTOG): RTOG 83 15. Int J Rad Oncol Biol Phys 23: 1, 9–C17
Ng CS, Chan JK, Hui PK, Lau WH (1989) Large B-cell lymphomas with a high content of reactive T-cells. Hum Pathol 20: 12, 1145–C1154
O¡¯Neill BP, O¡¯Fallon JR, Earle JD, Colgan JP, Brown LD, Krigel RL (1995) Primary central nervous system non-Hodgkin¡¯s lymphoma: survival advantages with combined initial therapy? Int J Rad Oncol Biol Phys 33: 3, 663–C673
Peterson K, Gordon KB, Heinemann MH, DeAngelis LM (1993) The clinical spectrum of ocular lymphoma. Cancer 72: 3, 843–C849
Rampen FH, van Andel JG, Sizoo W, van Unnik JA (1980) Radiation therapy in primary non-Hodgkin¡¯s lymphomas of the CNS. Eur J Cancer 16: 2, 177–C184
Raphael M, Gentilhomme O, Tulliez M, Byron PA, Diebold J (1991) Histopathologic features of high-grade non- Hodgkin¡¯s lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors. Arch Pathol Lab Med 115: 1, 15–C20
Reni M, Ferreri AJ, Garancini MP, Villa E (1997) Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol 8: 3, 227–C234
Rockwood EJ, Zakov ZN, Bay JW (1984) Combined malignant lymphoma of the eye and CNS (reticulum-cell sarcoma). Report of three cases. J Neurosurg 61: 2, 369–C374
Rosenblum ML, Levy RM, Bredesen DE, So YT, Wara W, Ziegler JL (1988) Primary central nervous system lymphomas in patients with AIDS. Ann Neurol Suppl 23: S13–C16
Rouah E, Rogers BB, Wilson DR, Kirkpatrick JB, Buffone GJ (1990) Demonstration of Epstein-Barr virus in primary central nervous system lymphomas by the polymerase chain reaction and in situ hybridization. Hum Pathol 21: 5, 545–C550
Rubinsten LJ (1972) Tumors of the cerebral nervous system: atlas of tumor pathology; second series, Fascicle 6. Washington, DC: Armed Forces Institute of Pathology 215
Schneck SA, Penn I (1971) De-novo brain tumors in renaltransplant recipients. Lancet 1: 7707, 983–C986
Schultz C, Scott C, Sherman W, Donahue B, Fields J,Murray K,Fisher B, Abrams R, Meis Kindblom J (1996) Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88–C06. J Clin Oncol 14: 2, 556–C564
Schwaighofer BW, Hesselink JR, Press GA, Wolf RL, Healy ME, Berthoty DP (1989) Primary intracranial CNS lymphoma: MR manifestations. Am J Neuroradiol 10: 4, 725–C729
Scott TF, Hogan EL, Carter TD, Garen PD, Brillman J, Kurent JE (1990) Primary intracranial meningeal lymphoma. Am J Med 89: 4, 536–C538
Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla Favera R, Neri A, Guttierez M, Levine P, Magrath I (1991) Patterns of chromosomal breakpoint locations in Burkitt¡¯s lymphoma: relevance to geography and Epstein-Barr virus association. Blood 77: 7, 1516–C1526
Singh A, Strobos RJ, Singh BM, Rothballer AB, Reddy V, Puljic S, Poon TP (1982) Steroid-induced remissions in CNS lymphoma. Neurology 32: 11, 1267–C1271
Snider WD, Simpson DM, Aronyk KE, Nielsen SL (1983) Primary lymphoma of the nervous system associated with acquired immune-deficiency syndrome. [letter]N Engl J Med 308: 1, 45
So YT, Beckstead JH, Davis RL (1986) Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann Neurol 20: 5, 566–C572
So YT, Choucair A, Davis RL, et al. (1988) Neoplasm of the central nervous system in acquired immunodeficiency syndrome. In: Rosenblum ML, Levy RM, Bredesen DE, (ed) AIDS and the Nervous System. Raven Press, New York 285
Strauchen JA, Dalton J, Friedman AH (1989) Chemotherapy in the management of intraocular lymphoma. Cancer 63: 10, 1918–C1921
Swinnen LJ, Costanzo-Nordin MR, Fisher SG, O¡¯Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Pifarre R, Fisher RI (1990) Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 323: 25, 1723–C1728
Szekely L, Selivanova G, Magnusson KP, Klein G, Wiman KG (1993) EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA 90: 12, 5455–C5459
Taylor CR, Russell R, Lukes RJ, Davis RL (1978) An immunohistological study of immunoglobulin content of primary central nervous system lymphomas. Cancer 41: 6, 2197–C2205
Valluri S, Moorthy RS, Khan A, Rao NA (1995) Combination treatment of intraocular lymphoma. Retina 15: 2, 125–C129
Vaquero J, Martinez R, Rossi E, Lopez R (1984) Primary cerebral lymphoma: the ¡°ghost tumor¡±. Case report. J Neurosurg 60: 1, 174–C176
Vokes EE, Ultmann JE, Golomb HM, Gaynor ER, Ferguson DJ, Griem ML, Oleske D (1985) Long-term survival of patients with localized diffuse histiocytic lymphoma. J Clin Oncol3: 10, 1309–C1317
Welch K, Finkbeiner W, Alpers CE, Blumenfeld W, Davis RL, Smuckler EA, Beckstead JH (1984) Autopsy findings in the acquired immune deficiency syndrome. JAMA 252: 9, 1152–C1159
Whitcup SM, de Smet MD, Rubin BI, Palestine AG, Martin DF, Burnier M Jr, Chan CC, Nussenblatt RB (1993) Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 100: 9, 1399–C1406
Woodman R, Shin K, Pineo G (1985) Primary non-Hodgkin¡¯s lymphoma of the brain. A review. Medicine 64: 6, 425–C430
Ziegler JL, Drew WL, Miner RC, Mintz L, Rosenbaum E, Gershow J, Lennette ET, Greenspan J, Shillitoe E, Beckstead J, Casavant C, Yamamoto K (1982) Burkitt¡¯s-like lymphoma in homosexual men. Lancet 2: 8299, 631–C633
Zimmerman HM (1975) Malignant lymphomas of the nervous system. Acta Neuropathol Suppl (Berlin) Suppl 6: 69–C74
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Formenti, C.S., Bettini, A. (2003). Treatment of CNS Lymphomas. In: Petrovich, Z., Brady, L.W., Apuzzo, M.L.J., Bamberg, M. (eds) Combined Modality Therapy of Central Nervous System Tumors. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56411-6_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-56411-6_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00627-5
Online ISBN: 978-3-642-56411-6
eBook Packages: Springer Book Archive